Comparative IP-MS Reveals HSPA5 and HSPA8 Interacting with Hemagglutinin Protein to Promote the Replication of Influenza A Virus
Pathogens · 2025
DOI: 10.3390/pathogens14060535 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Pathogens, 2025. Verfasst von Xingwei Feng und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, No. 2 Yuan Ming Yuan West Road, Hai D…. Hauptthemen laut MEDLINE: Virus Replication, Influenza A virus, Hemagglutinin Glycoproteins, Influenza Virus, Heat-Shock Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Waterfowl-industry Technology Research System.
Abstract (Originalsprache)
The influenza A viruses (IAV) are the principal pathogens for annual (seasonal) influenza, which cause world-wide outbreaks in poultry and pose a persistent threat to public health. The Hemagglutinin protein (HA) of IAV promotes virus infection by binding the host membrane receptor and mediating virus–host membrane fusion. Immunoprecipitation–mass spectrometry (IP-MS) provides global insights into IAV HA–host protein interactions. However, various experimental conditions might affect the identification of interactions. Here, we performed a serial IP-MS to compare interactors of IAV HA in accidental host human, chicken and reservoir host duck cells. We found that the positive ratio of interactors identified by the IP-MS was improved when the transfected HA plasmid had a similar expression level to HA proteins found in IAV virus infection. Comparing interactors in human, chicken and duck cells, we found that HA–interacting host factors might play a role in the susceptibility of accidental hosts (human and chicken) to IAV infection compared to reservoir hosts (duck). We then focused on the function of two heat shock proteins (HSPA5 and HSPA8), which interacted with IAV HA proteins in all three species (human, chicken and duck). We found that both HSPA5 and HSPA8 promoted the IAV replication by enhancing the viral attachment and internalization. These findings extend our knowledge about the mechanisms of IAV entry to host cells and provide target genes to create chickens resistant to avian influenza.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, No. 2 Yuan Ming Yuan West Road, Hai Dian District, Beijing 100193, China.
- Frontiers Science Center for Molecular Design Breeding (MOE), China Agricultural University, Beijing 100193, China.
- Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing 100193, Ch…
Förderung
- National Key Research and Development Program of China
- National Waterfowl-industry Technology Research System
Zitieren
APA
Feng, X., Ning, M., Chen, B., Li, X., Sun, H., Pu, J., Liu, J., Wang, N., & Huang, Y. (2025). Comparative IP-MS Reveals HSPA5 and HSPA8 Interacting with Hemagglutinin Protein to Promote the Replication of Influenza A Virus. Pathogens. https://doi.org/10.3390/pathogens14060535
Vancouver
Feng X, Ning M, Chen B, Li X, Sun H, Pu J, et al. Comparative IP-MS Reveals HSPA5 and HSPA8 Interacting with Hemagglutinin Protein to Promote the Replication of Influenza A Virus. Pathogens. 2025. doi:10.3390/pathogens14060535
BibTeX
@article{Feng2025,
author = {Feng, Xingwei and Ning, Mengfei and Chen, Bin and Li, Xuan and Sun, Honglei and Pu, Juan and Liu, Jinhua and Wang, Na and Huang, Yinhua},
title = {Comparative IP-MS Reveals HSPA5 and HSPA8 Interacting with Hemagglutinin Protein to Promote the Replication of Influenza A Virus},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14060535}
}
EUVIMED